Addition of the anti-allergy drug cyproheptadine, a su(var)3-9, enhancer-of-zeste and trithorax-domain containing lysine methyltransferase 7 (SET7) (also known as SET9) histone methyltransferase inhibitor, abrogated the induction of trained immunity by IL4 (Fig. 2g). The gene discussed is SETD7; the disease is allergic disease.